Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 24(13): 1967-73, 1997 Oct.
Article in Japanese | MEDLINE | ID: mdl-9350244

ABSTRACT

The most appropriate time for administration was studied based on examination of the total number of leukocytes, differential white blood count, and the number of platelets in 30 cases in which 200 micrograms Romurtide (Nopia) was injected subcutaneously on the day of radiotherapy, 5 times a week, for 2 weeks, totally 10 times because leukopenia was caused during treatment with radiotherapy. It was recognized that the number of leukocytes, mainly neutrophils, increased from 1 week after starting administration of Romurtide to after the completion of administration (2 weeks after administration), except 1 week after completion of administration. The increasing effect in the number of platelets was not recognized, and it had decreased from at the completion of administration to 1 week after the completion of administration of Romurtide. The rate of completion of radiotherapy was 100% without any serious adverse events, but there were 4 cases in which fever was observed. Therefore, it is not very favorable to administer Romurtide immediately after radiation, taking account of the treatment period of radiotherapy. It is also considered that it would be necessary to start radiation after sufficient recovery of the number of leukocytes or increase in their number by using G-CSF preparation in cases in which the leukocyte count has fallen since starting radiation due to the influence of the preceding chemotherapy.


Subject(s)
Acetylmuramyl-Alanyl-Isoglutamine/analogs & derivatives , Adjuvants, Immunologic/administration & dosage , Neoplasms/radiotherapy , Acetylmuramyl-Alanyl-Isoglutamine/administration & dosage , Adult , Aged , Aged, 80 and over , Drug Administration Schedule , Female , Humans , Leukocyte Count , Leukopenia/prevention & control , Male , Middle Aged , Neoplasms/blood , Time Factors
2.
Nihon Igaku Hoshasen Gakkai Zasshi ; 53(3): 249-53, 1993 Mar 25.
Article in Japanese | MEDLINE | ID: mdl-8474858

ABSTRACT

CT scans were performed 40 times in 28 postcystectomy patients to identify the type and location of tumor recurrence. Sixteen patients showed tumor recurrence. Patients without recurrence showed a complete symmetric pelvis and a thin string that looked like an operation scar. Cutaneous ureterostomy showed small tube-like structures, and ileal conduit looked like herniation of the ileum. Cases with recurrent tumors were divided into 3 patterns, 1) pelvic abscess recurrence, 2) anterior abdominal wall thickening, 3) pelvic lateral wall thickening, and combinations of these types. The abscess-recurrence type often showed air within the mass or a fuzzy contour that could not be differentiated from true inflammatory abscess. Anterior abdominal wall thickening was usually accompanied with abscess-type recurrence and appeared as thickening of the operation scar. Lateral wall thickening was usually seen at the site of the obturator internus muscle or obturator node. Patients without recurrence had no complaints except for two who had ileus. All patients with recurrence except one had complaints of pain, abnormal secretion, or a palpable mass. Because all patients with recurrence already had a relatively large tumor at the time of CT, routine follow-up CT is recommended even if the patient has no complaints.


Subject(s)
Carcinoma, Transitional Cell/surgery , Cystectomy , Neoplasm Recurrence, Local/diagnostic imaging , Tomography, X-Ray Computed , Urinary Bladder Neoplasms/surgery , Carcinoma, Transitional Cell/epidemiology , Female , Humans , Japan/epidemiology , Male , Neoplasm Recurrence, Local/epidemiology , Retrospective Studies , Urinary Bladder Neoplasms/epidemiology
4.
Gan No Rinsho ; 32(13): 1743-51, 1986 Oct.
Article in Japanese | MEDLINE | ID: mdl-3025470

ABSTRACT

To evaluate the therapeutic effect of surgery combined with radiotherapy in lung cancer, 385 operative cases, and 308 received combined treatment, were analyzed. The 5-year survival rate of T3 cases among pTNM-stage III cases undergoing surgery was 2.4% (1/42), while that of cases receiving combined radiotherapy was 18.9% (14/74), which showed some effectiveness. The 5 year survival rate of N2 (n3), operation only cases and combined treatment cases were 5.3% (2/38), and 8.9% (8/90), respectively. Long-term survival among cases of extensive mediastinal metastasis (# 1-9) confirmed the effect of combined therapy. Combined therapy effect was recognized in squamous cell carcinoma.


Subject(s)
Lung Neoplasms/radiotherapy , Pneumonectomy , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Adult , Aged , Carcinoma, Small Cell/radiotherapy , Carcinoma, Small Cell/surgery , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/surgery , Combined Modality Therapy , Female , Humans , Lung Neoplasms/surgery , Lymphatic Metastasis , Male , Middle Aged , Prognosis , Radiotherapy Dosage , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...